{"id":"W2778283729","doi":"10.1001/jama.2017.18718","title":"Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma","year":2017,"lang":"en","type":"article","venue":"JAMA","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2595,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; Ottawa Hospital","funders":"UCB Pharma; National Cancer Institute; Pharmacyclics; Genentech; NRG Oncology; Five Prime Therapeutics; Incyte; Celldex Therapeutics; Novocure; Servier; Pfizer; Teva Pharmaceutical Industries; Acceleron; AstraZeneca; Bristol-Myers Squibb","keywords":"Temozolomide; Medicine; Glioblastoma; Oncology; Internal medicine; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}